Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: A meta-analysis

European Journal of Cancer

Volumn 50, Issue 9, 2014, Pages 1628-1637

  Shim, Seung Hyuk ^a   Lee, Sun Joo ^a   Kim, Soo Nyung ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

Endometrial cancer; Hormone replacement therapy; Meta Analysis; Recurrence

Indexed keywords

ESTROGEN; GESTAGEN;

ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVOR; ENDOMETRIUM CANCER; HORMONE SUBSTITUTION; HUMAN; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; SYSTEMATIC REVIEW; THERAPY EFFECT;

ENDOMETRIAL CANCER; HORMONE REPLACEMENT THERAPY; META-ANALYSIS; RECURRENCE;

AGED; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURVIVORS;

EID: 84901191028     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.03.006     Document Type: Article

References (34)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. M.C. Lim, E.-K. Moon, and A. Shin et al. Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010 J Gynecol Oncol 24 2013 298 302
3. E. Darai, A. Gompel, and B. Deval et al. Hormone replacement therapy after endometrial or ovarian cancer Gynecol Obstet Fertil 28 2000 198 204
4. R. Michaelson-Cohen, and U. Beller Managing menopausal symptoms after gynecological cancer Curr Opin Oncol 21 2009 407 411
5. K. Hancke, M. Foeldi, H.P. Zahradnik, G. Gitsch, L. Gilbert, and D. Denschlag Estrogen replacement therapy after endometrial cancer: a survey of physicians' prescribing practice Climacteric 13 2010 271 277
6. D.F. Stroup, J.A. Berlin, and S.C. Morton et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
7. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and Group P Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 2009 e1000097
8. Wells G, Shea B, O'connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In: 3rd Symposium on systematic reviews: beyond the basics; 2000. p. 3-5.
9. O. Aziz, V. Constantinides, and P.P. Tekkis et al. Laparoscopic versus open surgery for rectal cancer: a meta-analysis Ann Surg Oncol 13 2006 413 424
10. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
11. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
12. R.G. Orwin A fail-safe N for effect size in meta-analysis J Educ. Stat. 8 1983 157
13. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
14. J.A. Sterne, and M. Egger Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis J Clin Epidemiol 54 2001 1046 1055
15. J.A. Sterne, M. Egger, and G.D. Smith Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis BMJ 323 2001 101 105
16. W.T. Creasman, D. Henderson, W. Hinshaw, and D.L. Clarke-Pearson Estrogen replacement therapy in the patient treated for endometrial cancer Obstet Gynecol 67 1986 326 330
17. R.B. Lee, T.W. Burke, and R.C. Park Estrogen replacement therapy following treatment for stage I endometrial carcinoma Gynecol Oncol 36 1990 189 191
18. J.A. Chapman, P.J. DiSaia, K. Osann, P.D. Roth, D.L. Gillotte, and M.L. Berman Estrogen replacement in surgical stage I and II endometrial cancer survivors Am J Obstet Gynecol 175 1996 1195 1200
19. K.A. Suriano, M. McHale, C.E. McLaren, K.T. Li, A. Re, and P.J. DiSaia Estrogen replacement therapy in endometrial cancer patients: a matched control study Obstet Gynecol 97 2001 555 560
20. R.R. Barakat, B.N. Bundy, N.M. Spirtos, J. Bell, R.S. Mannel, and Gynecologic Oncology Group S Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study J Clin Oncol 24 2006 587 592
21. A. Ayhan, C. Taskiran, S. Simsek, and A. Sever Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors? Int J Gynecol Cancer 16 2006 805 808
22. C. Lauritzen Östrogensubstitution in der Postmenopause vor und nach behandeltem Genital- und Mammakarzinom: Menopause: Hormonsubstitution heute 1993 Aesopus Verlag Basel p. 76-80
23. G.W. Bryant Administration of estrogens to patients with a previous diagnosis of endometrial adenocarcinoma South Med J 83 1990 725 726
24. D.P. Baker Estrogen-replacement therapy in patients with previous endometrial carcinoma Compr Ther 16 1990 28 35
25. G. Gitsch, E. Hanzal, D. Jensen, and N.F. Hacker Endometrial cancer in premenopausal women 45 years and younger Obstet Gynecol 85 1995 504 508
26. G.L. Maxwell, C. Tian, J.I. Risinger, C.A. Hamilton, R.R. Barakat, and Gynecologic Oncology Group S Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy? Cancer 113 2008 1431 1437
27. M. Levgur Estrogen and combined hormone therapy for women after genital malignancies: a review J Reprod Med 49 2004 837 848
28. A. Kendall, M. Dowsett, E. Folkerd, and I. Smith Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors Ann Oncol 17 2006 584 587
29. J.E. Rossouw, G.L. Anderson, and R.L. Prentice et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
30. C.F. Holinka, H. Hata, H. Kuramoto, and E. Gurpide Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa) J Steroid Biochem 24 1986 85 89
31. Y.Z. Farnell, and N.H. Ing The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells J Steroid Biochem Mol Biol 84 2003 453 461
32. G. Samsioe The endometrium: effects of estrogen and estrogen-progestogen replacement therapy Int J Fertil Menopausal Stud 39 Suppl. 2 1994 84 92
33. S.F. Li, T. Shiozawa, K. Nakayama, T. Nikaido, and S. Fujii Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma Cancer 77 1996 321 329
34. J.A. Sterne, D. Gavaghan, and M. Egger Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature J Clin Epidemiol 53 2000 1119 1129